Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT03295942
What this trial is testing

OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMetastatic Cancer
OncoMed Pharmaceuticals, Inc. 24
Early research (Phase 1)Active Not RecruitingNCT02142803
What this trial is testing

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Who this might be right for
Adult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT07483554
What this trial is testing

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

Who this might be right for
CLDN18.2 PositiveGastric/Gastroesophageal Junction AdenocarcinomaPancreatic Ductal Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd. 389
Testing effectiveness (Phase 2)UnknownNCT05216965
What this trial is testing

A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd. 208
Testing effectiveness (Phase 2)Looking for participantsNCT05733000
What this trial is testing

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Colorectal CarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma+30 more
Northwestern University 94
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Early research (Phase 1)Study completedNCT00958724
What this trial is testing

Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Puma Biotechnology, Inc. 6
Early research (Phase 1)Study completedNCT00635791
What this trial is testing

Phase I Study of Vorinostat and Sorafenib in Advanced Cancer

Who this might be right for
Malignant Solid TumourRenal Cell CarcinomaNon Small Cell Lung Carcinoma
University of Colorado, Denver 36
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Early research (Phase 1)UnknownNCT04981691
What this trial is testing

Anti-mesothelin CAR-T Cells With Advanced Refractory Solid Tumors

Who this might be right for
Refractory Malignant Solid Neoplasm
Ruijin Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT06499350
What this trial is testing

FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd. 33
Early research (Phase 1)Study completedNCT04200963
What this trial is testing

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUrothelial Carcinoma BladderBladder Cancer+18 more
Ikena Oncology 78
Early research (Phase 1)WithdrawnNCT03925428
What this trial is testing

Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmAnn Arbor Stage III B-Cell Non-Hodgkin Lymphoma+14 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01738139
What this trial is testing

Ipilimumab and Imatinib Mesylate in Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmC-KIT Tyrosine Kinase Protein OverexpressionClinical Stage IV Cutaneous Melanoma AJCC v8+6 more
M.D. Anderson Cancer Center 68
Early research (Phase 1)Study completedNCT02690337
What this trial is testing

Study of DS-1123a in Advanced Solid Tumours

Who this might be right for
Advanced Solid Malignant Tumors
Daiichi Sankyo Co., Ltd. 27
Early research (Phase 1)Study completedNCT01787500
What this trial is testing

Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

Who this might be right for
BRAF NP_004324.2:p.V600XKRAS wt AlleleMetastatic Malignant Solid Neoplasm+4 more
M.D. Anderson Cancer Center 47
Early research (Phase 1)Study completedNCT02565758
What this trial is testing

ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsUndifferentiated Pleomorphic SarcomaSquamous Cell Carcinoma of the Head and Neck+1 more
AbbVie 85
Early research (Phase 1)Study completedNCT05417750
What this trial is testing

A Phase I Study of GC101 TIL in Advanced Solid Tumors

Who this might be right for
Tumor Infiltrating LymphocytesSafetyAdvanced Solid Tumor+3 more
Shanghai Juncell Therapeutics 43
Next Page